MedPath

The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain

Not Applicable
Completed
Conditions
Nerve Pain
Signs and Symptoms
Peripheral Nervous System Diseases
Peripheral Nerve Injuries
Sciatica
Low Back Pain
Low Back Ache
Registration Number
NCT01954199
Lead Sponsor
Federal University of Health Science of Porto Alegre
Brief Summary

This study aims to verify if patients with nerve-related leg pain benefits from neurodynamic treatment over two weeks.

Detailed Description

Nerve-related leg pain (NRLP) although less prevalent than low back pain itself, is associated with higher economic and social burden, and has been considered a predictor of chronicity and disability among subjects with low back pain.

Numerous approaches are proposed for its management; however, evidence regarding the best therapeutic approach is lacking. Neurodynamic techniques are proposed to be effective to manage NRLP.

Thus, this study aims to verify, through a randomized controlled trial, the effectiveness of a two-week program of neurodynamic techniques on pain and disability in individuals with NRLP.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Leg Pain IntensityTwo weeks after randomization

Leg Pain will be measured by a 0-10 Numeric Rating Scale (Pain NRS)

DisabilityTwo weeks after randomization

Disability will be measured by the Oswestry Disability Index (ODI)

Secondary Outcome Measures
NameTimeMethod
Leg pain IntensityFour weeks after randomization

Leg Pain will me measured by a 0-10 Pain NRS

DisabilityFour weeks after randomization

Disability will be measured by the Oswestry Disability Index (ODI)

Back pain intensityFour weeks after randomization

Back Pain will me measured by an 0-10 Pain NRS

Distribution of SymptomsTwo weeks, Four weeks after randomization

Distribution of symptoms will me measured by a body diagram

FunctionTwo weeks, Four weeks after randomization

Function will be measured by the Patient-Specific Functional Scale (PSFS)

Global Perceived EffectTwo weeks, Four weeks after randomization

Global Perceived Effect will be measured by an 11-point (-5 to +5) Global Perceived Effect Scale

Trial Locations

Locations (1)

Federal University of Health Sciences of Porto Alegre

🇧🇷

Porto Alegre, Rio Grande do sul, Brazil

Federal University of Health Sciences of Porto Alegre
🇧🇷Porto Alegre, Rio Grande do sul, Brazil
© Copyright 2025. All Rights Reserved by MedPath